Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Donor Registries

Quality control of a national bone marrow donor registry: results of a pilot study and proposal for a standardized approach

Summary:

Unrelated hematopoietic stem cell transplantation (HSCT) is a recognized therapy for hematological diseases and over 8 million HLA-typed donors are ready to donate. Increased international exchanges and rapid requests through the Bone Marrow Donor Worldwide (BMDW) ask for standardized quality assurance. Since no such standards have been established to date, we tested a pilot program in order to evaluate donor availability and quality of HLA typing of the Swiss Registry.The 18500 donors of the registry have been analyzed by serology for HLA-AB and by molecular typing for HLA-DR. Through three successive annual quality control (QC) exercises, a total of 114 donor requests were sent to 13 blood transfusion centers responsible for donor recruitment asking for a blood sample. Donors were randomly selected according to recruitment periods (1988–1993; 1994–1997; 1998–2000), and to homozygosity for HLA-A and/or -B antigens. An additional 80 frozen blood samples from the repository corresponding to the three periods (n=26) and to the 2001 period (n=54) were also included in the HLA study. HLA-AB typings were done by polymerase chain reaction-sequence specific primers (PCR-SSP) and all discrepancies were retyped. The results showed that 79 samples provided by 69.3% of the requested donors were received within 14 days, and 19 samples (16.7%) were received in >14 days. Altogether, an 86% rate of donor availability was observed, independent of the recruitment period. Among the requested donors, 16 (14%) were not available: for medical reasons (two), for personal reasons (eight), for loss (one), and for an unknown reason (five). The HLA-A/B DNA typing results of 166 homozygous and 12 heterozygous blood samples showed that 437/439 (99.5%) of the assigned A/B antigens were correct. However in 36/178 donors (20.2%) an HLA-A or -B antigen had been missed (34 donors) or misassigned (two donors) by serology, with a decreasing discrepancy rate of 30% (1988–1993) to 18.5% in 2001. Assuming that HLA-A or -B homozygotes are found in 10–15% of the donors and that correct assignments have been observed in nearly 100% of the donors, an overall error rate of 4–5% would be expected for the national registry HLA-AB typing. These data show that standardized quality control for donor availability and HLA typing is feasible, and we propose that this model could be applied to the registries participating in bone marrow donor worldwide.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Gratwohl A, Passweg J, Baldomero H, Urbano-Ispizua A . European Group for Blood and Marrow Transplantation (EBMT). Hematopoietic stem cell transplantation activity in Europe 1999. Bone Marrow Transplant 2001; 27: 899–916.

    Article  CAS  Google Scholar 

  2. Anasetti C, Petersdorf EW, Martin PJ et al. Trends in transplantation of hematopoietic stem cells from unrelated donors. Curr Opin Hematol 2001; 8: 337–341.

    Article  CAS  Google Scholar 

  3. Oudshoorn M, Cornelissen JJ, Fibbe WE et al. Problems and possible solutions in finding an unrelated bone marrow donor. Results of consecutive searches for 240 Dutch patients. Bone Marrow Transplant 1997; 20: 1011–1017.

    Article  CAS  Google Scholar 

  4. Tiercy JM, Bujan-Lose M, Chapuis B et al. Bone marrow transplantation with unrelated donors: what is the probability of identifying an HLA-A/B/Cw/DRB1/B3/B5/DQB1-matched donor? Bone Marrow Transplant 2000; 26: 437–441.

    Article  CAS  Google Scholar 

  5. Darke C . An overview of the Welsh bone marrow donor registry: 10 years of bone marrow donor provision. Bone Marrow Transplant 2000; 25: 771–777.

    Article  CAS  Google Scholar 

  6. Chang YW, Hawkins BR . Comparison of serologic HLA class I results in a bone marrow donor registry with results obtained by DNA methods. Transplant Proc 1998; 30: 3486–3487.

    Article  CAS  Google Scholar 

  7. Mytilineos J, Lempert M, Middleton D et al. HLA class I DNA typing of 215 ‘HLA-A, -B, -DR zero mismatched’ kidney transplants. Tissue Antigens 1997; 50: 355–358.

    Article  CAS  Google Scholar 

  8. Mytilineos J, Lempert M, Scherer S et al. Comparison of serological and DNA PCR-SSP typing results for HLA-A and HLA-B in 421 Black individuals: a Collaborative Transplant Study report. Hum Immunol 1998; 59: 512–517.

    Article  CAS  Google Scholar 

  9. Lorentzen DF, Iwanaga KK, Meuer KJ et al. A 25% error rate in serologic typing of HLA-B homozygotes. Tissue Antigens 1997; 50: 359–365.

    Article  CAS  Google Scholar 

  10. Bozon MV, Delgado JC, Selvakumar A et al. Error rate for HLA-B antigen assignment by serology: implications for proficiency testing and utilization of DNA-based typing methods. Tissue Antigens 1997; 50: 387–394.

    Article  CAS  Google Scholar 

  11. Schaffer M, Olerup O . HLA-AB typing by polymerase-chain reaction with sequence-specific primers: more accurate, less errors, and increased resolution compared to serological typing. Tissue Antigens 2001; 58: 299–307.

    Article  CAS  Google Scholar 

  12. Noreen HJ, Yu N, Setterholm M et al. Validation of DNA-based HLA-A and HLA-B testing of volunteers for a bone marrow registry through parallel testing with serology. Tissue Antigens 2001; 57: 221–229.

    Article  CAS  Google Scholar 

  13. Gourley IS, Kearns J, McKeen M et al. HLA Class I typing of volunteers for a bone marrow registry: QC analysis by DNA-based methodology identifies serological typing discrepancies in the assignment of HLA-A and B antigens. Tissue Antigens 2002; 59: 211–215.

    Article  CAS  Google Scholar 

  14. Nicoloso de Faveri G, Kern M, Schneider P . Le Registre suisse des donneurs de moelle. Med Hyg 2002; 2389: 858–862.

    Google Scholar 

Download references

Acknowledgements

We thank the volunteer donors of the Swiss Registry and all regional blood transfusion centers for their cooperation to this QC project.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to J-M Tiercy.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tiercy, JM., Stadelmann, S., Chapuis, B. et al. Quality control of a national bone marrow donor registry: results of a pilot study and proposal for a standardized approach. Bone Marrow Transplant 32, 623–627 (2003). https://doi.org/10.1038/sj.bmt.1704229

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1704229

Keywords

This article is cited by

Search

Quick links